-
An article published in npj Aging reveals that natural production of auto-antibodies increases with age, and that infection by SARS-CoV-2 can exacerbate production of auto-antibodies relating to auto-immune diseases, helping to explain why aging increases the chances of developing severe COVID-19. The study also discovered some of the factors that associate the severe form of the disease with blood clotting disorders such as thrombosis.
"These findings open the door to a better [...]
-
Estudo publicado nesta quinta-feira (24/08) na revista NPJ Aging, do grupo Nature, revela que a infecção causada pelo vírus SARS-CoV-2 pode disparar a produção de autoanticorpos – moléculas relacionadas, entre outros fatores, às doenças autoimunes. O achado explica por que os idosos tendem a ser mais suscetíveis à COVID-19 e o motivo de a forma grave da doença estar relacionada com distúrbios de [...]
-
María Fernanda Ziegler
Un estudio realizado en la Universidad de Sao Paulo, en Brasil, ayuda a entender por qué las personas de la tercera edad son más susceptibles a contraer la infección provocada por el SARS-CoV-2 y el motivo por el cual la forma grave de la enfermedad aparece asociada a trastornos de la coagulación
Un estudio publicado en la revista NPJ Aging, perteneciente al grupo Nature, revela que la infección causada por el virus [...]
-
O uso de terapias celulares em pacientes com COVID-19 reduziu em 60% o risco de morte pela doença. A conclusão, divulgada na revista Frontiers in Immunology, é de um estudo de revisão conduzido por pesquisadores da Universidade de São Paulo (USP) em parceria com cientistas alemães e norte-americanos. O artigo compila dados de 195 ensaios clínicos feitos em 30 países, entre janeiro de 2020 e dezembro de 2021.
Nos últimos anos, as [...]
-
2023 OCT 1 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- An article published in NPJ Aging, a Springer Nature journal, reveals that natural production of auto-antibodies increases with age and that infection by SARS-CoV-2 can exacerbate production of auto-antibodies relating to auto-immune diseases, helping to explain why aging increases the chances of developing severe COVID-19. The study also discovered some of the factors that associate the severe [...]
-
Despite massive studies representing millions of participants that demonstrate associations between COVID-19 and autoimmune disease, whether the virus can actually cause autoimmunity remains unsettled.
Among the seemingly ever-growing list of yet unanswered questions in this space is the issue of autoantibody formation during the acute phase of infection. Another concerns whether COVID-19 can cause new-onset or reactivated autoimmune disease. Yet another is whether or not these [...]
-
The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.
Their findings are reported in an article published in Frontiers in Immunology.
The review covers 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 [...]
-
SÃO PAULO, Brazil — In the global fight against COVID-19, researchers have unveiled groundbreaking results that could potentially change the course of treatment for infected patients.
Collaborative research spanning three countries suggests a substantial decrease in the risk of death from COVID-19 by using advanced medical cell therapy.
Cell therapy , mainly using multipotent mesenchymal stem cells, has gained traction in recent years as an effective treatment for various [...]
-
Científicos brasileños y colaboradores internacionales compilaron datos de 195 ensayos clínicos realizados en 30 países entre enero de 2020 y diciembre de 2021. Pese a que la información es prometedora, los autores remarcan la necesidad de lograr un mayor control en la elaboración de los productos utilizados en este tipo de tratamientos.
La utilización de las terapias celulares en pacientes con Covid-19 hizo que disminuyera un 60 % el riesgo [...]
-
Il revient… Encore une fois. Le Covid-19 reprend du poil de la bête en cette rentrée et fait peau neuve avec un nouveau variant : le sous-variant d’Omicron appelé Pirola. Les mesures barrière sont donc de nouveau recommandées pour lutter contre l’épidémie. Des gestes essentiels, surtout si l’on prend en compte cette nouvelle information tirée d’une étude publiée dans la revue scientifique npj [...]